nVerses Capital’s Camtek CAMT Stock Holding History

nVerses Capital’s Portfolio CAMT Stock Details CAMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,000	Closed	-$376K	–	1042
2024 Q2	$376K	Buy	+3,000	New	+$286K	0.22%	142

Other funds holding CAMT

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

nVerses Capital's CAMT Position: Q3 2024 in Review

nVerses Capital sold out of Camtek (CAMT) in Q3 2024, closing a stake of 3,000 shares — an estimated $376K sold.

nVerses Capital first reported a position in CAMT in Q2 2024 and held it in 1 quarter. The position peaked at $376K in Q2 2024. 223 funds tracked by Wall St. Rank hold CAMT as of Q3 2024.

nVerses Capital reported no remaining Camtek position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 3,000 Camtek shares in Q3 2024, an estimated $376K.
nVerses Capital first reported a position in Camtek in Q2 2024 and held it in 1 quarter.
nVerses Capital's Camtek position peaked at $376K in Q2 2024.
223 funds tracked by Wall St. Rank held Camtek as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.